Literature DB >> 35180211

Avoiding data loss: Synthetic MRIs generated from diffusion imaging can replace corrupted structural acquisitions for freesurfer-seeded tractography.

Jeremy Beaumont1,2, Giulio Gambarota2, Marita Prior3, Jurgen Fripp1, Lee B Reid1.   

Abstract

Magnetic Resonance Imaging (MRI) motion artefacts frequently complicate structural and diffusion MRI analyses. While diffusion imaging is easily 'scrubbed' of motion affected volumes, the same is not true for T1w or T2w 'structural' images. Structural images are critical to most diffusion-imaging pipelines thus their corruption can lead to disproportionate data loss. To enable diffusion-image processing when structural images are missing or have been corrupted, we propose a means by which synthetic structural images can be generated from diffusion MRI. This technique combines multi-tissue constrained spherical deconvolution, which is central to many existing diffusion analyses, with the Bloch equations that allow simulation of MRI intensities for given scanner parameters and magnetic resonance (MR) tissue properties. We applied this technique to 32 scans, including those acquired on different scanners, with different protocols and with pathology present. The resulting synthetic T1w and T2w images were visually convincing and exhibited similar tissue contrast to acquired structural images. These were also of sufficient quality to drive a Freesurfer-based tractographic analysis. In this analysis, probabilistic tractography connecting the thalamus to the primary sensorimotor cortex was delineated with Freesurfer, using either real or synthetic structural images. Tractography for real and synthetic conditions was largely identical in terms of both voxels encountered (Dice 0.88-0.95) and mean fractional anisotropy (intrasubject absolute difference 0.00-0.02). We provide executables for the proposed technique in the hope that these may aid the community in analysing datasets where structural image corruption is common, such as studies of children or cognitively impaired persons.

Entities:  

Mesh:

Year:  2022        PMID: 35180211      PMCID: PMC8856573          DOI: 10.1371/journal.pone.0247343

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


1 Introduction

Diffusion magnetic resonance imaging (MRI) is a form of medical imaging that can indirectly quantify certain aspects of tissue microstructure related to myelination [e.g. 1], axon density [2], or cellular death. It also can, via tractography, delineate axonal pathways from which such microstructural measurements can be taken. These abilities make diffusion MRI a popular means of identifying and quantifying brain reorganisation and injury [3-5]. Studies utilising diffusion MRI commonly attempt to report measurements in specific white-matter tracts, or in specific regions of interest, which almost invariably requires identification of cortical or subcortical structures. Such parcellation typically relies upon an aligned structural MR image, such as a T1- or T2-weighted scan (referred to herein as ‘structural images’ for simplicity). This reliance is because most standard neuroimaging packages that can provide parcellations, such as Freesurfer [6], have been optimised for high-resolution images displaying particular tissue contrasts that are not apparent in diffusion images. The reliance on structural images to complete diffusion analyses can introduce four difficulties into analysis pipelines. Firstly, cross-modality registration sometimes fails due to the meaningful difference between tissue contrasts combined with the typically low (2–2.5mm) spatial resolution of diffusion images [7]. Poor registration can be subtle, leading to biased measurements, or major, preventing analysis outright. Attempts have been made to tackle this issue through, for example, inverting the T1 contrast [8], registering T1 images to fractional anisotropy maps [9], or relying on mutual information as a registration cost function [10]. Such approaches only partially address contrast differences, however, and so cross-modal registration can still present as a major point-of-failure for fully-automated pipelines [9]. Multimodal registration can also prove computationally expensive and misregistrations can be time consuming to identify and correct. Secondly, diffusion images typically display geometric distortions that are not found in structural images and can prevent perfect registration. The severity of such distortions depends on the scan parameters [11], and in some instances can be substantial. Correction of geometric distortion requires reverse-phase-encoded images or fieldmaps [11]. When such images are collected, correction often works reasonably well; when these are lost, corrupted, or difficult to use due to patient motion between scans, adequate registration is difficult or impossible to achieve. Although some specialised registration tools exist for such circumstances, the correction of eddy currents purely using registration can be problematic [11], and in the presence of larger deformations these tools can still leave several millimetres of misregistration between modalities [7]. Thirdly, reliance on structural MR images provides a greater risk that motion artefacts or other data loss will prevent analysis. In particular, diffusion MR sequences have a reasonable tolerance for motion as motion-affected volumes can be rejected from the 4D series and still leave sufficient information for analysis [12]. Conversely, the retrospective methods for correction of motion-corrupted structural images are usually based on the use of raw k-space data to obtain motion-robust image reconstructions [13-15], thus preventing their use for most studies in which the raw k-space data is not collected. The corruption of MR images with motion is particularly prevalent in young children and populations with brain injury, who are highly valuable participants but also highly likely to move during scanning [16] and often less tolerant to remaining in the scanner for repeat scans. Although less common, it is also possible that structural data can be corrupted, collected incorrectly, or simply lost. In such situations, the loss of structural images can completely preclude the analysis of the diffusion data using standard tools. As a concrete example, the constrained spherical deconvolution model [17] is commonly used for tractography and requires 45 uncorrupted diffusion encoding directions (assuming b = 3000s/mm2) [18, 19]. This means 15 motion-affected volumes (25% of the acquired volumes) can be safely deleted from a classic 60-direction single-shell scan and the data remain analysable. We have previously reported on 123 scans of children and adolescents, the majority of whom had disability [20, 21]. Reviewing these data, 63% of scans demonstrated motion artefacts in the diffusion scan but only 3.3% had 15 or more motion-affected volumes out of the 60 acquired. By contrast, 25% of structural scans displayed artefacts that precluded both structural and atlas-driven diffusion analyses [16]. Finally, diffusion acquisitions are typically limited to a lower spatial or angular resolution than desired due to scan time requirements. The requirement for high-quality structural images reduces the time available for diffusion acquisitions and thus their quality. Best practice is, where possible, to pre-allocate additional scan time for the re-acquisition of motion affected structural images, which further reduces available time for diffusion scans. This particularly affects studies of populations where motion artefacts are commonplace because substantial time must be allowed for re-acquisition of potentially several motion-affected images. In this study we demonstrate a straightforward means of generating synthetic T1w and T2w images from a typical diffusion acquisition to allow for diffusion MRI analysis when in-vivo T1w and T2w images have been lost or motion corrupted. This process takes advantage of recent advances that allow approximate calculation of tissue compartments from both multishell [22] and single shell [19] diffusion images. We demonstrate that by combining these modern methods with MRI simulation based on the use of the Bloch equations [23], synthetic images can be produced that are of sufficient quality to be used in place of genuine structural images in some standard diffusion tractography analyses. In many circumstances, this may eliminate the need to re-acquire motion-corrupted structural images or to reject participants from analysis due to poor quality structural images. We are aware of three previous reports in this field. Roy et al. [24] proposed a means of generating T2w images, through multi-atlas registration and patch-matching, though this method relied on the collection of adequate-quality T1w images. More simply, Dhollander and Connelly [25] normalized a single diffusion-MR derived segmentation voxel-wise and multiplied it by experimentally derived values in order to generate an image qualitatively similar to a T1w image. Similarly, Cheng et al. [26] thresholded the b0 and a mean-diffusivity-like images to identify grey-matter- and white-matter-like tissues, then applied numerical constants to combine into a T1-like image. These latter approaches both generated T1-like images, but their utility is potentially limited by relying qualitative thresholding approaches to tissue segmentations, and a lack of a physical basis for conversion to the structural image. The present work extends beyond these works by demonstrating how one can utilise established segmentation approaches that require only diffusion data and perform genuine sequence simulation that allows arbitrary T1 or T2 contrasts to be generated. We demonstrate these techniques in both healthy individuals and those with sizeable pathology.

2 Methods

We first describe our proposed method to simulate structural MRIs using diffusion data, then describe in-vivo experiments designed to assess this method.

2.1 Proposed method

Our proposed method, summarised in Fig 1, requires that multi-tissue fibre orientation dispersion (FOD) maps have been calculated from diffusion MR data. These maps can be calculated from both single-shell and multi-shell diffusion acquisitions using standard tools without reliance on structural MR images. An example of this process is described in Section 3.2.2.
Fig 1

Summary of the proposed MRI synthetization method.

After extracting the tissue components of the multi-tissue fibre orientation maps (FOD), partial volume (PV) maps are computed and used to generate synthetic T1w and T2w contrast with Bloch equations-based simulations.

Summary of the proposed MRI synthetization method.

After extracting the tissue components of the multi-tissue fibre orientation maps (FOD), partial volume (PV) maps are computed and used to generate synthetic T1w and T2w contrast with Bloch equations-based simulations. Once calculated, the white matter (WM), grey matter (GM) and cerebrospinal fluid (CSF) tissue components of the FOD maps are extracted and used to generate partial volume (PV) maps as follows: Where PV and TC indicate the partial volume and the FOD tissue component of tissue A, respectively, and TC, TC and TC indicate the WM, GM and CSF tissue components of the FOD. The analytical solution of the Bloch equations for a selected sequence can then be applied to these PV maps to synthesize structural MR images. In the present study, we focus on T1-w and T2-w MRI signals which can be simulated using the following equations: Where S and S are the analytical solutions of the Bloch equations for the MPRAGE [27] and Spin Echo [28] sequences; Θ and Θ represent the sequence parameters of the MPRAGE and spin echo sequences; and Φ, Φ and Φ correspond to the magnetic properties of the WM, GM and CSF tissues, respectively. Utilisation of Eqs 2 and 3 requires selection of scanning parameters and tissue magnetic properties. In the current study, the T1w scans were simulated with the ADNI MPRAGE sequence parameters (α = 9°, TE = 2.9 ms, TI = 900 ms, TR = 2300 ms) [29]. Similarly, the T2w spin-echo scans were simulated with standard sequence parameters used in clinical imaging (TE = 80 ms, TR = 4500 ms) [30]. The tissue magnetic properties used to simulate the T1w and T2w signals were measured in previous studies conducted at 3T and are summarized in Table 1 [31-33].
Table 1

Magnetic properties of white matter (WM), gray matter (GM) and cerebrospinal fluid (CSF) used for the T1w and T2w signal simulations.

These magnetic properties were measured in previous studies conducted at 3T [31–33].

WMGMCSF
T1(ms)83013304000
T2 (ms)801101000
T2* (ms)5366250
ρ 1 0.70.81.0

1 The reported proton densities (ρ) are relative measures compared to the CSF proton density.

Magnetic properties of white matter (WM), gray matter (GM) and cerebrospinal fluid (CSF) used for the T1w and T2w signal simulations.

These magnetic properties were measured in previous studies conducted at 3T [31-33]. 1 The reported proton densities (ρ) are relative measures compared to the CSF proton density.

2.2 In-vivo experiments

We applied the proposed method to several diffusion datasets in order to assess the quality of the resulting images in terms of qualitative appearance, quantitative tissue contrast, and fitness for use as an integral component of a diffusion tractography pipeline.

2.2.1 Input data

Three datasets, named herein as the ‘Human Connectome Project Multishell’ (HCP-M), ‘Human Connectome Project Single Shell’ (HCP-S) and ‘Hospital’ datasets, were used in the current study. Scans in these datasets were mostly a convenient sample which had been preprocessed as part of a recent tractography study [9]. The HCP-M dataset included 10 healthy participants from the Human Connectome Project Young Adults 1200 Release [34]. Participants had been scanned twice on a Siemens Skyra Connectom scanner (Siemens Healthcare, Erlangen, Germany) with a 32-channel head coil. We used the preprocessed [35] T1w MPRAGE (1 mm isotropic; α = 8°; TE = 2.14 ms; TI = 1000 ms; TR = 2400 ms; acquisition time 7m 40s), T2w SPACE (1mm isotropic; TE = 565 ms; TR = 3200 ms; acquisition time 8m 24s) data, and preprocessed multishell diffusion data derived from a high quality acquisition (18 @ b = 0s/mm2; 90 directions @ b = 1000s/mm2; 90 directions @ b = 2000s/mm2; 90 directions @ b = 3000s/mm2; 1.25mm isotropic). For test-retest experiments (See Section 3.2.4), we utilised structural scans from two time points. For other experiments, only the first time point was used. Ethical consent was granted for use of HCP data. The HCP-S dataset included the same participants as the HCP-M dataset, excepting that raw data were used (see below) for the diffusion data, which were downsampled and volumes were removed such that only a single shell remained (2 @ b = 0s/mm2; 60 directions @ b = 3000s/mm2; no directional repeats; 2mm isotropic). This dataset was designed to represent a modest single-shell HARDI acquisition often seen in the literature. The Hospital dataset consisted of 12 neurosurgical patients scanned once on a Siemens Prisma scanner with a 64-channel head coil at the Herston Imaging Research Facility in Brisbane, Australia. Images were acquired as part of a clinical trial involving temporal lobe resection for epilepsy (n = 3 before surgery, n = 6 after surgery), glioma resection (n = 2 before surgery), or removal of arteriovenous malformations (n = 1 before surgery). This study included acquisition of a T1w MPRAGE scan (1mm isotropic, α = 9°; TE = 2.9 ms; TI = 900 ms; TR = 1900 ms; acquisition time 4m 18s) and a modern multishell diffusion acquisition (12 @ b = 0s/mm2; 20 directions @ b = 2000s/mm2; 30 directions @ b = 1000s/mm2; 60 directions @ b = 3000s/mm2; 2mm isotropic; acquisition time 11m 30s) that is in use in a variety of studies [36-38]. Written informed consent was provided by all patients and the study approved by the Royal Brisbane and Women’s Hospital (RBWH) Human Research Ethics Committee.

2.2.2 Diffusion MRI processing

Diffusion data from the HCP-S and Hospital datasets were processed automatically using the CONSULT neurosurgical planning pipeline [9]. This pipeline prepared raw diffusion data for tractography using standard libraries and algorithms without requiring associated structural images. Steps included denoising via MRtrix 3.0 [39], removal of motion-corrupted volumes, brain mask calculation using MRtrix’s dwi2mask, and eddy-current distortion correction using a combination of FSL’s topup (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/TOPUP) and eddy_cuda 8.0. Subsequently, intensity inhomogeneities were corrected using N4-ITK [40]. A final brainmask was then recalculated using MRtrix’s dwi2mask in conjunction with simple morphological operations. Diffusion data from the HCP-M dataset were downloaded from the HCP server in their minimally preprocessed form. This preprocessing included correction for b0 intensity inhomogeneities, EPI distortion, eddy currents, head motion, gradient non-linearities, as well as reorientation and resampling to 1.25 mm isotropic. Brainmasks for these data were calculated in the same way as for HCP-S and Hospital datasets. Tissue response functions were calculated using an unsupervised method [41] and FOD maps were calculated for white matter, grey matter, and cerebrospinal fluid using either multishell multitissue contrained spherical deconvolution (for multishell images) [22] or Single-Shell 3-Tissue constrained spherical deconvolution [19] (https://3Tissue.github.io; for HCP-S images). Fractional anisotropy (FA) maps were also calculated from the preprocessed data using MRtrix. Synthetic T1w and T2w scans were generated from the resulting FOD maps, for all the three datasets, using the method described in Section 3.1.

2.2.3 Synthetic and in-vivo structural image comparisons

One standard means of assessing structural image quality is measuring intensity contrasts between brain tissues. Here, the brain-tissue contrasts of the in-vivo and synthetic structural images were measured using the following equation: Where S and S refer to the mean signal intensity of tissues A and B, respectively. The contrast between brain tissues was measured in regions of interest (ROI) manually drawn in the corpus callosum for WM, caudate nucleus for GM and lateral ventricles for CSF. Each ROI comprised at least 20 contiguous voxels. To ensure that the contrast was comparable between scans with different resolutions, specific care was taken to avoid the inclusion of partial volume voxels within the ROIs. The zero-normalized cross correlation was computed to further assess the similarity between the in-vivo and synthetic structural scans. This metric was preferred over standard similarity metrics, such as the structural similarity index, as it does not require that the images being compared have the same intensity range (T1w MPRAGE and T2w spin-echo contrasts are qualitative, and so repeat scans and synthetic images do not necessarily lie in the same intensity range as the first in-vivo image). To allow for the computation of the zero-normalized cross correlation, the synthetic images were spatially normalized to the in-vivo images using the affine registration tool provided by ANTS 2.1 [42]. The brain masks computed in the diffusion image space (see section 3.2.2) were then propagated in the structural image space to skull-strip the in-vivo images. The zero-normalized cross-correlation was computed as follows: With Ω the set of voxels within the brain masks; N the number of voxels within the brain mask; I (respectively ) the intensity of a given voxel k in the in-vivo (respectively synthetic) image; and μ and σ (respectively and ) the mean and standard deviation of the in-vivo (respectectively synthetic) brain tissue intensities.

2.3 Comparative performance in a diffusion tractography pipeline

We tested whether the synthetic images were of sufficiently high quality to be used in a standard Freesurfer-based diffusion tractography pipeline, described below. Similar to other tractography-generating processes, this pipeline required structural images for parcellation and diffusion images for tractography. For each subject, we ran this pipeline using (A) in-vivo structural scans acquired during the same scan session as the diffusion data (all datasets); (B) in-vivo structural scans acquired during a different scan session as the diffusion data (‘in-vivo repeat’; HCP-M and HCP-S only); or (C) the synthetically generated structural scans (all datasets). The diffusion FOD image did not differ between each subject’s acquisitions. To determine the influence of the structural scan on reproducibility of this pipeline, we compared these subjects’ acquisitions in terms of both (1) spatial overlap of binarised tractography (Dice score) and (2) differences in FA and mean diffusivity (MD) sampled from this tractography. The former measure was to ascertain how synthetic structural images could impact the tractography itself. The latter was conducted to assess the practical significance of any error introduced by synthetic structural images, as the sampling of FA and MD are common use-cases for tractography. All image processing was fully automated to avoid biasing results; no manual correction or process re-running was performed for any processing stage. Parcellation of structural images was performed using Freesurfer 6.0 [6]. Both the T1w and T2w images belonging to the HCP-M and HCP-S datasets were provided to Freesurfer. However, only the T1w images were utilised for the Hospital dataset because in-vivo T2w scans were not available. When structural images were acquired in-vivo, the resulting parcellation was spatially normalized to the diffusion space by affinely registering the T1w scan to either the FA image (HCP-M and HCP-S) or mean ‘b0’ image (Hospital dataset) using ANTS 2.1 [42]. The mean ‘b0’ image was used for the Hospital dataset as it was already known to produce registrations of better quality for this particular dataset. When structural images were synthetic, no spatial normalization was required because image synthesis naturally creates images in native diffusion space. The left superior thalamocortical tract was delineated using probabilistic tractography, using labels extracted from the Freesurfer parcellations. Specifically, the thalamus was used as the seeding ROI, while the left primary sensory cortex and left primary motor cortex were combined into a single inclusion ROI. Maximum streamline length was 80 mm. Streamlines were acquired using iFOD2 [43] until Tractography Bootstrapping stability criteria [44] were met to ensure the tractogram’s reproducibility was not negatively affected by a low streamline count (minimum streamline count: 1000; min Dice: 0.975; reliability: 0.95; 1.25 mm isotropic; t: 0.001 × n streamlines). Other parameters were left at default values. Subject-wise results were compared across runs. To assess overlap between tractograms, each tractogram was converted into a streamline density image at native diffusion resolution, thresholded at the Tractogram Bootstrapping stability threshold (t), and binarised, in line with recommendations for when Tractogram Bootstrapping has been used [44]. The Dice scores between the binarised tractograms of each run were then calculated. To assess reproducibility of microstructural metrics, FA and MD were sampled from each tractogram using MRtrix’s ‘tcksample’ [e.g. 4, 45, 46].

2.3.1 Comparison of Freesurfer labels

Our white-matter tract delineation was designed to indicate whether one could use synthetic images to perform a standard Freesurfer-reliant tractography pipeline but we acknowledge that this does not utilise all Freesurfer-delineated regions. As such, we compared labels provided by Freesurfer using the generalised Dice similarity coefficient (gDSC) [47]. The gDSC is an adaption of the Dice Similarity Coefficient that can summarise overlap between identical labels when multiple labels are present. For each subject and pipeline we calculated one gDSC considering the 70 cortical grey matter labels, and another gDSC considering 16 deep grey matter labels. These were calculated as follows: With N the number of labels; i the value of voxel n for label l in the in-vivo image, s the value of voxel n for label l in the synthetic image. To ensure relevance to tractography, gDSC was calculated on parcellations in diffusion space. Furthermore, as tractography typically is seeded from or terminates at the grey-matter/white-matter interface, we restricted these labels to voxels in contact with the white matter (18-connectivity), as defined by the Freesurfer parcellation in question.

4. Results

4.1 Image quality and contrast

An example of PV maps generated from FOD tissue components is presented in Fig 1. Examples of synthetic T1w and T2w scans are presented in Fig 2. Qualitatively, all synthetic scans displayed a similar appearance to their corresponding in vivo scan, albeit at the resolution of their diffusion scan (1.25 or 2mm isotropic). Despite this limitation, the borders of individual gyri and subcortical structures were still easily identifiable in all images. Tissue contrast was qualitatively similar between in-vivo and synthetic images, despite small differences in acquisition and simulation protocols (Figs 1 and 2). Specifically, the synthetic T1w scans were characterized by a good suppression of the CSF signal and by a high contrast between grey matter, white matter, and CSF, as is typical for MPRAGE acquisitions. Similarly the synthetic T2w scans displayed comparable tissue contrasts to those of the in-vivo T2w scans, including the typical hyper-intensity of the CSF signal. Synthetic images derived from single and multi-shell diffusion scans produced similar tissue contrast, despite relying on meaningfully different diffusion FOD algorithms and resolutions. Notably, images were also realistic for patients with tumours and post-surgical cavities.
Fig 2

In-vivo and synthetic T1w and T2w images obtained from the HCP-M (far left), HCP-S (middle left) and Hospital (middle and far right) datasets. The synthetic T1w images display contrasts qualitatively similar to that of the in-vivo scans for all datasets, even in presence of tumours (middle right) and post-surgical cavities (far right). The T2w contrast was similar between the synthetic and in-vivo scans for the HCP-M and HCP datasets, including the expected hyper-intensity of the cerebrospinal fluid signal. For the Hospital dataset, the in-vivo T2w images were not acquired but synthetic images provided similar contrast to that which could be expected from an in-vivo scan, including in the areas of pathology.

In-vivo and synthetic T1w and T2w images obtained from the HCP-M (far left), HCP-S (middle left) and Hospital (middle and far right) datasets. The synthetic T1w images display contrasts qualitatively similar to that of the in-vivo scans for all datasets, even in presence of tumours (middle right) and post-surgical cavities (far right). The T2w contrast was similar between the synthetic and in-vivo scans for the HCP-M and HCP datasets, including the expected hyper-intensity of the cerebrospinal fluid signal. For the Hospital dataset, the in-vivo T2w images were not acquired but synthetic images provided similar contrast to that which could be expected from an in-vivo scan, including in the areas of pathology. The quantitative brain tissue contrast measurements obtained for both T1w and T2w synthetic images were close to their in-vivo counterparts for the HCP-M, HCP-S and Hospital datasets (Tables 2 and 3). The brain tissue contrasts were not significantly different between in-vivo and synthetic images (Tables 2 and 3), except for the T1w WM/GM contrast in the Hospital dataset (Bonferroni-corrected Wilcoxon signed rank test, p = 0.02) and the WM/CSF and GM/CSF contrasts in the HCP-M dataset (Bonferroni-corrected Wilcoxon signed rank tests, both p = 0.04). The contrast difference between in-vivo and synthetic images remained very small for these cases (Tables 2 and 3).
Table 2

Mean brain tissue contrast measured for in-vivo and synthetic T1w scans on the Hospital, HCP-M and HCP-S datasets.

WM/GMWM/CSFGM/CSF
MeanRangep-valueMeanRangep-valueMeanRangep-value
In-vivo Hospital0.140.12–0.15N/A0.590.56–0.65N/A0.490.46–0.55N/A
In-vivo HCP0.120.09–0.15N/A0.560.54–0.59N/A0.470.45–0.49N/A
Synthetic Hospital0.090.07–0.120.020.560.52–0.600.300.490.47–0.521.00
Synthetic HCP-M0.100.07–0.120.100.500.39–0.600.170.430.31–0.550.34
Synthetic HCP-S0.130.10–0.151.000.500.42–0.580.070.400.33–0.480.05

HCP datasets used identical in-vivo structural images and so appear together in one row. P-values indicate comparisons of in-vivo vs synthetic contrasts using Bonferroni-corrected Wilcoxon signed rank tests. The contrasts measured for the synthetic scans are similar to the contrasts measured for the in-vivo scans, despite slight differences between the imaging protocols.

Table 3

Mean brain tissue contrast measured for in-vivo and synthetic T2w scans on the Hospital, HCP-M and HCP-S datasets.

WM/GMWM/CSFGM/CSF
MeanRangep-valueMeanRangep-valueMeanRangep-value
In-vivo HCP0.160.12–0.21N/A0.530.50–0.57N/A0.410.37–0.44N/A
Synthetic Hospital0.150.11–0.19N/A0.580.56–0.59N/A0.470.44–0.48N/A
Synthetic HCP-M0.160.13–0.181.000.580.55–0.590.040.460.42–0.490.04
Synthetic HCP-S0.190.16–0.230.170.550.51–0.580.920.400.36–0.441.00

P-values indicate comparisons of in-vivo vs synthetic contrasts using Bonferroni-corrected Wilcoxon signed rank tests. P-values for the Hospital dataset are unavailable as no in-vivo T2w scan was acquired for this dataset. The synthetic HCP-M dataset WM/CSF and GM/CSF contrasts are significantly higher than their in-vivo counterparts. Although the absolute WM/CSF and GM/CSF contrast difference remained very small. The other synthetic contrasts were very close to their in-vivo counterparts, despite the use of different magnetic resonance sequences to acquire and simulate the signals.

HCP datasets used identical in-vivo structural images and so appear together in one row. P-values indicate comparisons of in-vivo vs synthetic contrasts using Bonferroni-corrected Wilcoxon signed rank tests. The contrasts measured for the synthetic scans are similar to the contrasts measured for the in-vivo scans, despite slight differences between the imaging protocols. P-values indicate comparisons of in-vivo vs synthetic contrasts using Bonferroni-corrected Wilcoxon signed rank tests. P-values for the Hospital dataset are unavailable as no in-vivo T2w scan was acquired for this dataset. The synthetic HCP-M dataset WM/CSF and GM/CSF contrasts are significantly higher than their in-vivo counterparts. Although the absolute WM/CSF and GM/CSF contrast difference remained very small. The other synthetic contrasts were very close to their in-vivo counterparts, despite the use of different magnetic resonance sequences to acquire and simulate the signals. A very strong zero-normalized cross-correlation was measured between the co-registered T1w in-vivo and synthetic images for the Hospital (mean: 0.87; range: 0.82–0.90), HCP-M (mean: 0.86; range: 0.84–0.87) and HCP-S (mean: 0.86; range: 0.83–0.88) datasets. The zero-normalized cross-correlation measured between the co-registered T2w in-vivo and synthetic images was strong for both HCP-M (mean: 0.75; range: 0.67–0.80) and HCP-S (mean: 0.68; range: 0.64–0.73) datasets.

4.2 Comparative performance in a diffusion tractography pipeline

Freesurfer succeeded for all but one participant. This participant, from the Hospital dataset, presented with a glioma in the left temporal lobe, preventing adequate Freesurfer performance when provided with either in-vivo or synthetic input data (Fig 2, middle-left column). A qualitative assessment indicated that Freesurfer parcellations obtained from synthetic datasets were similar to those obtained from in-vivo data, as shown in Fig 3. Notably, near the white matter/grey matter interface, from which tractography is typically seeded, Freesurfer parcellations were qualitatively similar between corresponding synthetic and in vivo images. However, the synthetic images at 2mm resolution often produced inaccurate segmentation of the pial surface by Freesurfer (Fig 3, S1 Table in S1 File).
Fig 3

Example of freesurfer parcellations obtained from the in-vivo (left) and synthetic (right) scans of the Hospital dataset.

The bottom row shows a magnified section of the frontal lobe. A qualitative assessment indicated that the synthetic parcellations were similar to the in-vivo parcellations in subcortical structures and near the grey-matter/white-matter interface from which tractography is typically seeded. However, the lower resolution provided by the synthetic data (2 mm isotropic) reduced the accuracy of the pial surface segmentation, as highlighted by the green arrows.

Example of freesurfer parcellations obtained from the in-vivo (left) and synthetic (right) scans of the Hospital dataset.

The bottom row shows a magnified section of the frontal lobe. A qualitative assessment indicated that the synthetic parcellations were similar to the in-vivo parcellations in subcortical structures and near the grey-matter/white-matter interface from which tractography is typically seeded. However, the lower resolution provided by the synthetic data (2 mm isotropic) reduced the accuracy of the pial surface segmentation, as highlighted by the green arrows. Tractography was successfully performed for all the datasets for which Freesurfer parcellation did not fail. Tractography was qualitatively similar between in-vivo- and synthetic-structural pipelines (Fig 4). Median Dice coefficients for binarised tractography between the in-vivo- and synthetic-structural pipelines were 0.93 (HCP-M), 0.93 (HCP-S), and 0.90 (Hospital) with respective worst-case performances of 0.90, 0.90, and 0.88 (Fig 5). Structural scans were available from a second time point for all HCP datasets. The tractography pipeline was repeated using the same diffusion data but with these alternative in-vivo structural scans. These in-vivo vs in-vivo-repeat comparisons demonstrated similar median Dice coefficients to, and poorer worst-case performance than, the aforementioned in-vivo vs synthetic comparisons (Fig 5). Numerical differences between the in-vivo-repeat and the synthetic Dice coefficients were not statistically significant for HCP-S or HCP-M datasets (Bonferroni-corrected Wilcoxon Signed-Rank Tests, both p>0.1; see Fig 5). The poorer worst case performance of the in-vivo-repeat analysis may be explained by variations in the quality of registration between structural and diffusion scans: a step not required by the synthetic pipeline which guarantees perfect alignment between modalities.
Fig 4

Example tractography from the in-vivo and synthetic pipelines.

The rightmost column shows overlap of the in-vivo tractography (from the leftmost column; green) with the synthetic tractography (fuchsia; white indicating overlap). Tractography densities showed clear correspondences between in vivo and synthetic pipelines for HCP-S, Hospital, and HCP-M datasets. The datasets shown here were selected at random.

Fig 5

The tractography pipeline was run first using genuine (‘in-vivo’) diffusion and structural MR images, and then run again using the same diffusion data but with either a synthetic structural image (‘synthetic’) or a structural scan acquired during another scanning session (‘in-vivo repeat’).

Top: Dice scores for overlap of tractography between runs using in-vivo data and either synthetic or in-vivo repeat data. Median dice scores did not differ significantly between synthetic and in-vivo repeat runs after correction for multiple comparisons. Bottom: Mean tract FA values sampled from the tractography, compared with the in-vivo tractography. Differences between the in-vivo versus synthetic or in-vivo-repeat runs were below the level of practical significance. Approximate percentages were calculated by dividing differences by the mean FA of all datasets (0.52). Displayed p-values are corrected for multiple comparisons.

Example tractography from the in-vivo and synthetic pipelines.

The rightmost column shows overlap of the in-vivo tractography (from the leftmost column; green) with the synthetic tractography (fuchsia; white indicating overlap). Tractography densities showed clear correspondences between in vivo and synthetic pipelines for HCP-S, Hospital, and HCP-M datasets. The datasets shown here were selected at random.

The tractography pipeline was run first using genuine (‘in-vivo’) diffusion and structural MR images, and then run again using the same diffusion data but with either a synthetic structural image (‘synthetic’) or a structural scan acquired during another scanning session (‘in-vivo repeat’).

Top: Dice scores for overlap of tractography between runs using in-vivo data and either synthetic or in-vivo repeat data. Median dice scores did not differ significantly between synthetic and in-vivo repeat runs after correction for multiple comparisons. Bottom: Mean tract FA values sampled from the tractography, compared with the in-vivo tractography. Differences between the in-vivo versus synthetic or in-vivo-repeat runs were below the level of practical significance. Approximate percentages were calculated by dividing differences by the mean FA of all datasets (0.52). Displayed p-values are corrected for multiple comparisons. FA values sampled from tractography did not differ significantly between pipelines for the HCP-M or HCP-S datasets (Bonferroni-corrected Wilcoxon Signed-Rank tests versus the in-vivo-structural pipeline FA values: HCP-M Synthetic, p = 1; HCP-M in-vivo repeat, p = 1; HCP-S Synthetic, p = 0.11; HCP-S in-vivo repeat 0.37). Although a statistically significant difference was found between in-vivo and synthetic pipelines for the Hospital dataset (p = 0.02), this median difference was only 0.01, or 2.2%, which is well below both inter-group and longitudinal differences typically reported in imaging studies [4, 45, 46]. MD values sampled from tractography did not differ significantly between pipelines for the HCP-S dataset (Bonferroni-corrected Wilcoxon Signed-Rank tests versus the in-vivo-structural pipeline MD values: HCP-S Synthetic, p = 1; HCP-S in-vivo repeat, p = 1). In other datasets, all other comparisons with the first in-vivo pipeline showed differences that were significant, or bordered on significance (HCP-M in-vivo repeat, p = 0.01; HCP-M synthetic, p = 0.06; Hospital synthetic, p = 0.08), but these median differences (0.33%, 0.24%, and 0.78% respectively) were again well below inter-group and longitudinal differences of clinical or scientific significance [E.g. 4, 48].

4.3 Comparison of Freesurfer labels

Table 4 shows generalised Dice similarity coefficients for 70 cortical grey matter labels, or 16 deep grey-matter labels. These gDSCs reflect similarities between label obtained from the first in-vivo structural scan and labels obtained using either the repeat in-vivo structural scan or synthetic structural image. For the HCP-M dataset, median gDSCs were typically lower for synthetic images than repeat in-vivo data (p = 0.01 for both comparisons using uncorrected Wilcoxon Signed-Rank tests). The worst-case performances of in-vivo and synthetic pipelines were similar on this dataset. For the HCP-S dataset, differences between in-vivo and synthetic pipeline gDSCs were not statistically significant (p = 0.65 for cortical GM and p = 0.51 for deep GM using uncorrected Wilcoxon Signed-Rank tests). On the HCP-S dataset, the synthetic pipeline demonstrated considerably better worst-case performance than the in-vivo pipeline. Dice coefficients for Freesurfer-delineated tissues can be found in S1 Table in S1 File.
Table 4

Generalised Dice coefficients for 70 cortical grey matter labels (Cortical GM) or 16 deep grey-matter labels (Deep GM).

Cortical GMDeep GM
Synthetic Hospital0.56 (0.47–0.63)0.59 (0.57–0.63)
In-vivo Repeat HCP-M0.75 (0.34–0.76)0.70 (0.41–0.75)
Synthetic HCP-M0.59 (0.34–0.63)0.55 (0.40–0.62)
In-vivo Repeat HCP-S0.68 (0.17–0.90)0.74 (0.07–0.93)
Synthetic HCP-S0.60 (0.52–0.64)0.62 (0.54–0.69)
In-vivo Repeat vs Synthetic Dice Scores
HCP-Mp = 0.005p = 0.005
HCP-Sp = 0.65p = 0.51

Median values are shown; ranges appear in brackets. Dice coefficients are a comparison between the listed scan and the first in-vivo scan and restricted to voxels at the GM/WM interface in diffusion space. P-values indicate comparison of dice coefficients between in-vivo Repeat vs Synthetic scans using Wilcoxon signed rank tests.

Median values are shown; ranges appear in brackets. Dice coefficients are a comparison between the listed scan and the first in-vivo scan and restricted to voxels at the GM/WM interface in diffusion space. P-values indicate comparison of dice coefficients between in-vivo Repeat vs Synthetic scans using Wilcoxon signed rank tests.

5 Discussion

Motion artefacts are commonplace in MRI acquisition, particularly with children and cognitively impaired persons [16, 49]. Diffusion imaging can be easily ‘scrubbed’ of motion affected volumes, typically leaving usable data [18, 19]. However, the same is not true for structural images which are critical to most diffusion analyses. As such, motion or other corruption of structural images can lead to disproportionate data loss [16, 49]. To alleviate this issue, we have proposed a means by which synthetic structural images can be generated from diffusion MR images. We are aware of one previous report [25] in which a single diffusion-MR derived segmentation was normalised voxel-wise and multiplied by experimentally derived values in order to generate an image qualitatively similar to a T1w image. Similarly, Cheng et al. [26] applied thresholding to processed diffusion weighting images to identify grey-matter- and white-matter-like tissues, then applied constants to combine into a T1-like image. These latter approaches both generated T1-like images, but their utility is potentially limited by relying qualitative thresholding approaches to tissue segmentations, and a lack of a physical basis for conversion to the structural image. We have expanded on these ideas by using a well-established physical model that allows precise scanning parameters to be simulated; this is demonstrated here by the synthesis of specific T1w MPRAGE and T2w spin-echo sequences from both single-shell (HCP-S dataset) and multi-shell (HCP-M dataset, Hospital dataset) diffusion scans. We demonstrated that the synthetic images generated for these 32 participants, including those displaying pathology, were both visually convincing and had tissue contrasts in line with images acquired in-vivo. In addition, the strong zero-normalized cross-correlations measured between the synthetic and in-vivo images further highlighted their structural similarities. To demonstrate the utility of the proposed method, we performed Freesurfer-driven tractography for 32 participants. Freesurfer is a well-established program and is regularly relied on for diffusion analyses but can, like many packages, fail if low-quality images are provided. Here, Freesurfer was able to segment brains successfully in all instances for both in-vivo and synthetic data excepting for one subject presenting with a glioma for which it failed with both real and synthetic images. Due to the lower resolution of the synthetic data, the pial surface was not always as well defined in the synthetic-image parcellation as in the in-vivo image parcellation. However, this is unlikely to be of serious concern for tractography-based studies which are more reliant on an accurate grey-matter/white-matter interface, which was generally of reasonable quality (Fig 3), particularly for the 2mm HCP-S dataset (Table 4). Indeed, tractography derived from in-vivo structural and synthetic-structural parcellations overlapped well (median Dice ≥ 0.90) for all three types of diffusion acquisition tested in this study. A common use for tractography is to identify a tract from which microstructural measures, such as FA or MD, can be sampled. Here, FA and MD sampled from tractography of the in-vivo and synthetic-image pipelines differed well below the level of practical significance for most forms of analysis (Fig 5). An alternative to the proposed method, available only to longitudinal diffusion MRI studies, is to replace a corrupted structural image with another acquired at another time point. We tested the efficacy of this alternative for the HCP-S and HCP-M datasets by running the Freesurfer-based pipeline with T1w and T2w scans acquired at a second time point. In general, this did not produce meaningfully better results, in terms of tractography Dice scores, MD, or FA, than using a synthetic image. Visual inspection suggested that performance of this in-vivo-repeat run sometimes suffered from slight mis-registrations between the real structural images and diffusion images, reminding that the negative impact of the lower- resolution synthetic images is somewhat counter balanced by their guaranteed perfect alignment to the diffusion image. We also calculated generalised Dice coefficients (gDSC) for 70 cortical GM labels and 16 deep GM labels, at the GM/WM interface (Table 4). For the HCP-S dataset, gDSC scores for the synthetic and in-vivo repeat pipelines were comparable. Results for the HCP-M dataset, however, implied that groups who work with high resolution (1.25mm) diffusion data whose pipelines rely on a particularly accurate cortical parcellation would do best to rely on an in-vivo structural image (if available), rather than a synthetic structural image. The degree to which the differing parcellation accuracies will affect tractography depends on the specifics of the tractography. For example, when we performed tractography of the corticothalamic tracts in this study, we used cortical and thalamic ROIs from Freesurfer. The ROIs produced by the in-vivo pipeline had higher gDSC scores (median gDSCs of 0.73 for cortical GM, 0.64 for thalamus) than the synthetic pipeline (0.58 cortical GM, 0.48 thalamus). Nevertheless, these differences did not meaningfully affect the physical location of the tractography or the microstructural measurements taken from it (Fig 5). This may not be the case in all situations, but it serves as a reminder that subtle changes in seed or termination ROIs do not necessarily bias diffusion measurements. Notably, the worst-case performance was equal between the synthetic and in-vivo pipelines for high-resolution (HCP-M) diffusion data, while at the more typical resolution of 2mm (HCP-S), the synthetic pipeline had better worst-case performance than the in-vivo pipeline. Such results highlight that while a genuine structural image is usually preferable, when this is lost or corrupted a synthetic image can act as a worthwhile substitute. One strength to our method is a reliance on a well-established physical model that makes a relatively small number of assumptions. While hand-tuned or machine-learning based approaches could in principle generate similar outputs, these are inherently tuned to their training data, which sometimes leaves general use uncertain–for example, when presented with lesions, low quality data, or high resolution inputs. By contrast, our proposed method is resolution independent and, as demonstrated here, was able to generate convincing images from data acquired on two scanners, using two different tissue response function methods, and three different acquisition parameters. It also was able to produce convincing and usable images where pathology and post-surgical cavities were present without requiring tuning of any kind. One limitation of the current approach is the assumption that the brain tissues have the same relaxometry values for all subjects, while the subject relaxometry values may change due to the subject age or brain disease. However, the relaxometry values are used as input variables in the solutions of the Bloch equations for the synthetization of the structural images, thus allowing to easily tailor the model by using relaxometry values corresponding to the population of interest (ie. young vs aged subjects, type of pathology, …). Nevertheless, the proposed method is likely to not work for neonates as it models tissues that have not yet fully developed in the neonate brain. Our proposed method is dependent on the ‘single-shell 3-tissue’ (SS3T) or ‘multishell-multitissue’ (MSMT) diffusion models, which in turn are reliant on an adequate number of diffusion directions being available. We have not explored the effects of progressively reducing the number of directions to simulate movement because the requirements of SS3T and MSMT have already been explored [18, 19, 22]. Furthermore, our method has no additional requirements over those of typical tractography that uses constrained spherical deconvolution (at least 45 directions at a b-value of 3000s/mm2). If these requirements are not met high-quality tractography will not be possible, regardless as to whether an in-vivo or synthetic structural is used. Importantly, the proposed method is intended to enable diffusion MRI analyses of white matter; it is not intended to produce images for clinical interpretation nor for other types of analyses that would normally rely on precise tissue-contrast for certain pathologies or sharp pial surfaces. For this intended use-case, the major limitation of the proposed method is that the synthetic images produced are at the resolution of the diffusion data. Although it is possible to apply up-sampling and super-resolution techniques, we have not attempted to do so here because the synthetic images were of sufficient quality to obtain adequate quality parcellations and diffusion metrics. It is also worth considering that the proposed method provides some insurance against motion-corrupted structural images, therefore, scan time does not necessarily have to be pre-allocated for potential re-acquisition of motion-affected structural scans. This, in turn, may provide some studies with additional scan time that can potentially be used to modestly improve the resolution of their diffusion data. In conclusion, we have presented a simple and physically constrained means of synthesising structural images with customisable acquisition parameters from diffusion MRI. These images are of adequate quality to be used with standard parcellation tools, allowing analysis of diffusion data that would otherwise be impossible due to motion-corrupted or non-acquired scans. (ZIP) Click here for additional data file. 11 Jun 2021 PONE-D-21-03790 Avoiding Data Loss: Synthetic MRIs Generated from Diffusion Imaging Can Replace Corrupted Structural Acquisitions For Freesurfer-Seeded Tractography PLOS ONE Dear Dr. Beaumont, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.  In particular, all reviewers raised concerns about the need for quantitative data in the evaluation of the method.  In addition, it was suggested that several relevant papers should be cited and discussed. Please submit your revised manuscript by Jul 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see:  http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at  https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Dzung Pham Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. Thank you for stating the following in the Competing Interests/Financial Disclosure * (delete as necessary) section: This research was partially supported by an Advance Queensland Research Fellowship (R-09964-01) and by the ‘Region Bretagne’ (France - ARED_BITRAST) We note that you received funding from a commercial source: Advance Queensland Research Fellowship Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc. Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf." [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have presented and demonstrated a method to synthesize structural MRI data which would allow for increased use of scanning time for diffusion MRI data particularly in populations who are prone to movement during the scan. 1. One of the potential advantages of this method is that it could be used in a scenario with participants who move during the scan. Presumably there would be motion during the diffusion scan which could be corrected during processing. In the datasets presented in the paper how many volumes had to be excluded due to motion? Does motion affect the ability to generate the synthesized structural image and if so, to what extent? 2. Were there comparisons of fiber tract orientation or other tensor based metrics in addition to using FA as a quantitative metric to assess the quality of tractography using a synthetic structural image? A relevant paper to cite is by Hu Cheng et al (June 2020) titled "Segmentation of the brain using direction-averaged signal of DWI images. Adding this to the discussion would place the proposed method in context of current alternative approaches. Reviewer #2: This paper presents a physics based method for synthesizing T1w and T2w MR images from diffusion MR images, which first estimates tissue volume from diffusion data using multi-tissue spherical deconvolution, and then uses the estimated tissue volume for bloch simulation of different sequences such as MPRAGE. The method uses the synthesized T1w data for FreeSurfer reconstruction for brain segmentation, which is then used for delineating brain ROIs for diffusion tractography. This method is novel and interesting, and might be a potential useful tool for the neuroimaging community. The paper is clearly written, except for the intro which needs better motivation and literature review. The experiments are well designed but the evaluation of the proposed method should be more comprehensive and thorough. My detail comments are as below. (1) The introduction for diffusion MRI and structural MRI in the first paragraph is not very friendly to non-MRI readers. Maybe provide more background. Also maybe provide more explanations on why “such analyses almost always require identification of cortical or subcortical structures using an aligned structural MR image, such as a T1- or T2-weighted scan”. (2) The first paragraph to some extent provides some motivation on why “Such reliance on structural images can introduce four 4 difficulties into analysis pipelines”, which need some refinement and detailed explanation. The main issue between the co-reg between the T1w and the diffusion data is the susceptibility induced non-linear distortion present in the diffusion data. This non-linear distortion can be corrected e.g. using blip-up/blip-down b=0, but this data might be not acquired in some cases. The other main reason is that sometimes the T1w is also missing. Can refer to these papers: Little and Beaulieu. NeuroImage 2021, 237, 118105. Bhushan, Haldar, et al. NeuroImage 2015, 115, 269-280. (3) In general, the intro is too brief which requires more details. Also the intro needs to better discuss previous similar works and do a better literature review. (4) The paper only qualitatively compares the synthesized images and the actually acquired T1w or T1w images. Maybe consider comparing them quantitatively using metrics such as SSIM using up-sampled diffusion synthesized images. (5) Even though the brain segmentation is the main focus of the method, there is no evaluation or comparison of the FreeSurfer results from synthesized images and actual images, which is much easier to perform than for images. Figure 3 only shows tissue and cortical segmentation visually. The Dice coefficients or some overlapping metrics for the segmentation of each cortical area and each brain region from synthesize and actual images should be reported to quantify the performance of the proposed method. The segmentation from the diffusion synthesized images can be upsampled using nearest neighbour resampling. (6) Showing and comparing tractography results on only one tract, i.e., superior thalamocortical tract, is not sufficient. Results from more tracts need to be reported and ideally the whole-brain structural connectivity should be reconstructed and compared. The reconstruction of the structural connectivity requires the use of each segmented brain region from the synthesized images, and therefore could more accurately and comprehensively reflect the quality of the synthesized images and their FreeSurfer reconstruction results. Reviewer #3: Authors present an approach for generating synthetic T1w and T2w image from diffusion MRI images by using Bloch equations along with tissue partial volume estimates from diffusion MRI. The synthetic images are used in a diffusion tractography pipeline. The method is clearly described and results are presented on HCP and a private hospital data. In my opinion, the results do not provide evidence of robustness to nuisances and repetition of diffusion MRI acquisition. Also, the method assumes very simple tissue model parameter (table 1) that is assumed to be constant across population and throughout the brain, which will most likely be not true in scenarios "where structural image corruption is common, such as studies of children or cognitively impaired persons". My specific comments are below: - Same relaxometry value (table 1) is very simple. These values will most likely not match in children and subjects with cognitive impairment. Please comment and, if possible, include some results in children. - Because of the simple tissue model and that fact that "specific care was taken to avoid the inclusion of partial volume voxels within the ROIs" the contrast comparison (eq 4) does not sufficiently identify quality of synthetic images. Probably a difference map between in-vivo and synthetic image would be more meaningful (and compare how it look wrt difference map between in-vivo repeats). Also, in table 2, In-vivo Hospital and Synthetic Hospital differ a lot for WM/GM. - In all results, synthetic images are generated from same diffusion data. This does not provide evidence that the proposed method is robust to nuisances, motion and artifacts in diffusion data. It would have been specially interesting to see how it works when diffusion data is also corrupted by motion because subjects with motion in T1w/T2w images generally also have motion in diffusion. Also, its important to show repeatability of the method on diffusion data repeats. - Because same diffusion data is used for all results, it is expected that the results will have very similar tracks and FA values. The source of the difference are small changes in ROI seeding, which will have minor impact on the tracks. So, in my humble opinion, these results (fig 4-5) are expected because same diffusion data was used. - As the synthetic images are the only difference between these results (fig 4-5) - it is probably better to show dice and other metrics on freesurfer parcels (like thalamus etc.) than on binarised tractograms. - Line 256: if I understand correctly, the statistical testing is incorrectly used in these results. A failure to reject the null hypothesis in a significance test does not mean that the null hypothesis is true. Wilcoxon signed-rank test tests the null hypothesis that two related paired samples come from the same distribution. A large p-value implies that null hypothesis can not be rejected and so we can not conclude anything. - Line 294: "... accurate grey-matter/white-matter interface, which was generally of high quality here (Figure 3)." However the image show several differences in GM/WM boundaries. Please show difference map between synthetic and in-vivo image to justify this statement. - Line 175: While processing with in-vivo structural images affine registration was used to co-register T1 and diffusion images (FA/b=0). It is well known that EPI distortion will be not resolved by affine registration. This might be the main issue in fig 5 (line 256-258). - HCP-S dataset was chosen to have b-value of 3000s/mm2. Any reasons? It is related to use of CSD? Can results be included with b-value of 1000s/mm2, which is far more common. - There are some similarity of the presented method to following works. Authors should consider highlighting differences: Bhushan C et al. "Co-registration and distortion correction of diffusion and anatomical images based on inverse contrast normalization." NeuroImage. 2015;115:269–280. Roy, Snehashis, et al. "Patch based synthesis of whole head MR images: Application to EPI distortion correction." International Workshop on Simulation and Synthesis in Medical Imaging. Springer, Cham, 2016. Minor points: - "... structural images have been corrupted." However approach does not fix corruputed images but just replaces them. It abstract and introduction gives an impression that corrupted images are fixed. It should be clarified. - DWIs are also structural images. https://jnnp.bmj.com/content/75/9/1235 ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 6 Sep 2021 Please see the response to the reviewers in the document attached. Submitted filename: responseToReviewer_v06.pdf Click here for additional data file. 8 Oct 2021
PONE-D-21-03790R1
Avoiding Data Loss: Synthetic MRIs Generated from Diffusion Imaging Can Replace Corrupted Structural Acquisitions For Freesurfer-Seeded Tractography
PLOS ONE Dear Dr. Beaumont, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In particular, Reviewer 3 requested some clarifications about the goal of the algorithm and the statistical analysis.
 
Please ensure that your decision is justified on PLOS ONE’s publication criteria and not, for example, on novelty or perceived impact. For Lab, Study and Registered Report Protocols: These article types are not expected to include results but may include pilot data. ============================== Please submit your revised manuscript by Nov 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Dzung Pham Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) Reviewer #3: I thank authors for updating the manuscript and clarifying several issues in the last version. In my humble opinion following clarifications before publication will be valuable to the readers: - Based on the authors' responses and edits, it seems the intent and the ultimate goal of the proposed method is to obtain a synthetic T1w image that allows using existing DWI processing pipelines (like freesurfer) when an in-vivo T1w is absent. If so, I would suggest to further clarify this in abstract and introduction (Edits clarify it better in newer version, but can be further clarified). The earlier version gave impression that authors are suggesting a method that can replace in-vivo T1w/T2w images for all purposes. - By “same diffusion data” comment, I meant that no repeatability results are shown for same subject. With explanation on SS3T and MSMT diffusion models, that comment is addressed. - Can some statistical tests be added for results shown in table 2 and 3? This will help further strengthen the proposed method. - Line 363-365: Authors mention statistical results for HCP-S dataset (in-vivo vs synthetic ). How about statistical tests of HCP-M dataset? Median of 0.59 vs 0.75 seems to imply substantial differences. - Also, please report/add the statistical test results in table 4 and supplemental material as well. - Please report actual p-values of each statistical tests instead of just mentioning "P>0.05". This is widely accepted as good scientific practice. https://doi.org/10.1007/s10654-016-0149-3 ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
19 Nov 2021 Please find the response to the editor and reviewers comments in the document attached to this submission. Submitted filename: responseToReviewer2_v02.docx Click here for additional data file. 1 Dec 2021 Avoiding Data Loss: Synthetic MRIs Generated from Diffusion Imaging Can Replace Corrupted Structural Acquisitions For Freesurfer-Seeded Tractography PONE-D-21-03790R2 Dear Dr. Beaumont, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Dzung Pham Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: 9 Feb 2022 PONE-D-21-03790R2 Avoiding Data Loss: Synthetic MRIs Generated from Diffusion Imaging Can Replace Corrupted Structural Acquisitions For Freesurfer-Seeded Tractography Dear Dr. Beaumont: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr Dzung Pham Academic Editor PLOS ONE
  43 in total

1.  NMR relaxation times in the human brain at 3.0 tesla.

Authors:  J P Wansapura; S K Holland; R S Dunn; W S Ball
Journal:  J Magn Reson Imaging       Date:  1999-04       Impact factor: 4.813

2.  Detection and elimination of motion artifacts by regeneration of k-space.

Authors:  M Bydder; D J Larkman; J V Hajnal
Journal:  Magn Reson Med       Date:  2002-04       Impact factor: 4.668

3.  Biomarkers of disease in a case of familial lower motor neuron ALS.

Authors:  Fusun Baumann; Stephen E Rose; Garth A Nicholson; Nicole Hutchinson; Kerstin Pannek; Anthony Pettitt; Pamela A Mccombe; Robert D Henderson
Journal:  Amyotroph Lateral Scler       Date:  2010-10

4.  Routine clinical brain MRI sequences for use at 3.0 Tesla.

Authors:  Hanzhang Lu; Lidia M Nagae-Poetscher; Xavier Golay; Doris Lin; Martin Pomper; Peter C M van Zijl
Journal:  J Magn Reson Imaging       Date:  2005-07       Impact factor: 4.813

Review 5.  MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation.

Authors:  J-Donald Tournier; Robert Smith; David Raffelt; Rami Tabbara; Thijs Dhollander; Maximilian Pietsch; Daan Christiaens; Ben Jeurissen; Chun-Hung Yeh; Alan Connelly
Journal:  Neuroimage       Date:  2019-08-29       Impact factor: 6.556

6.  Generalized K-space analysis and correction of motion effects in MR imaging.

Authors:  M L Lauzon; B K Rutt
Journal:  Magn Reson Med       Date:  1993-10       Impact factor: 4.668

7.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

Review 8.  Rehabilitation and neuroplasticity in children with unilateral cerebral palsy.

Authors:  Lee B Reid; Stephen E Rose; Roslyn N Boyd
Journal:  Nat Rev Neurol       Date:  2015-06-16       Impact factor: 42.937

9.  The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Authors:  Clifford R Jack; Matt A Bernstein; Nick C Fox; Paul Thompson; Gene Alexander; Danielle Harvey; Bret Borowski; Paula J Britson; Jennifer L Whitwell; Chadwick Ward; Anders M Dale; Joel P Felmlee; Jeffrey L Gunter; Derek L G Hill; Ron Killiany; Norbert Schuff; Sabrina Fox-Bosetti; Chen Lin; Colin Studholme; Charles S DeCarli; Gunnar Krueger; Heidi A Ward; Gregory J Metzger; Katherine T Scott; Richard Mallozzi; Daniel Blezek; Joshua Levy; Josef P Debbins; Adam S Fleisher; Marilyn Albert; Robert Green; George Bartzokis; Gary Glover; John Mugler; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

10.  Discovering the sense of touch: protocol for a randomised controlled trial examining the efficacy of a somatosensory discrimination intervention for children with hemiplegic cerebral palsy.

Authors:  Belinda McLean; Misty Blakeman; Leeanne Carey; Roslyn Ward; Iona Novak; Jane Valentine; Eve Blair; Susan Taylor; Natasha Bear; Michael Bynevelt; Emma Basc; Stephen Rose; Lee Reid; Kerstin Pannek; Jennifer Angeli; Karen Harpster; Catherine Elliott
Journal:  BMC Pediatr       Date:  2018-07-31       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.